Cognitive and neuropsychiatric profiles distinguish atypical parkinsonian syndromes.
Hu MT. et al, (2025), Brain
Association of cholesterol and glycemic state biomarkers with phenotypic variation and Parkinson's disease progression: The Oxford Discovery cohort.
Ho Chiu NK. et al, (2025), J Parkinsons Dis
Single extracellular vesicle detection assay identifies membrane-associated α-synuclein as an early-stage biomarker in Parkinson’s disease
Yan S. et al, (2025), Cell Reports Medicine, 6, 101999 - 101999
LRRK2-associated parkinsonism with and without in vivo evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterization
Chahine LM. et al, (2025), Brain Communications, 7
Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson’s disease
Sauerbier A. et al, (2024), npj Parkinson's Disease, 10
A worldwide study of subcortical shape as a marker for clinical staging in Parkinson's disease.
Laansma MA. et al, (2024), NPJ Parkinsons Dis, 10
Evaluation of Cerebrospinal Fluid α-Synuclein Seed Amplification Assay in Progressive Supranuclear Palsy and Corticobasal Syndrome.
Vaughan DP. et al, (2024), Mov Disord
A worldwide study of white matter microstructural alterations in people living with Parkinson's disease.
Owens-Walton C. et al, (2024), NPJ Parkinsons Dis, 10
Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study.
Westenberger A. et al, (2024), Brain, 147, 2652 - 2667
Genome sequence analyses identify novel risk loci for multiple system atrophy.
Chia R. et al, (2024), Neuron, 112, 2142 - 2156.e5
Concerns with the new biological research criteria for synucleinopathy.
Boeve BF. et al, (2024), Lancet Neurol, 23, 659 - 660
Genome-wide determinants of mortality and motor progression in Parkinson's disease.
Tan MMX. et al, (2024), NPJ Parkinsons Dis, 10
Online cognitive monitoring technology for people with Parkinson's disease and REM sleep behavioural disorder.
Bălăeţ M. et al, (2024), NPJ Digit Med, 7
RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses.
Gustavsson EK. et al, (2024), Lancet Neurol
Motor Complications in Parkinson's Disease: Results from 3343 Patients Followed for up to 12 Years.
Gandhi SE. et al, (2024), Mov Disord Clin Pract
Presynaptic Dopaminergic Imaging Characterizes Patients with REM Sleep Behavior Disorder Due to Synucleinopathy.
Arnaldi D. et al, (2024), Ann Neurol
Frequency and outcomes of gastrostomy insertion in a longitudinal cohort study of atypical parkinsonism.
Kobylecki C. et al, (2024), Eur J Neurol